Business
SueWallSt Reminds FS KKR CAPITAL CORP. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - FSK
SueWallSt Reminds FS KKR CAPITAL CORP. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 -
About this update from Fs Kkr Capital Corp.
[{"type":"text","content":"FSK's Boilerplate Risk Warnings Allegedly Failed to Disclose That Portfolio Valuations Were Already Deteriorating and Non-Accrual Rates Were Climbing Toward Above-Industry Levels, Costing Investors $2.03 Per Share When the Truth EmergedNEW YORK, May 28, 2026 /PRNewswire/ -- SueWallSt examines the adequacy of FS KKR Capital Corp.'s (NYSE: FSK) risk disclosures during a period when investors lost $2.03 per share following corrective disclosures on February 25, 2026. Find out if you qualify to recover losses from inadequate FSK disclosures. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.FSK shares fell 15.24% on February 26, 2026, closing at $11.29 after the Company revealed its non-accrual rate had risen to 5.5% at amortized cost, above the long-term BDC industry average of 3.8%, and slashed its quarterly dividend from $0.70 to $0.48 per share. The lead plaintiff deadline is July 6, 2026.What the Company Disclosed in SEC FilingsThroughout the Class Period, FS KKR Capital's annual and quarterly reports contained generic risk language acknowledging that fair value determinations \"may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize.\" The FY24 10-K also warned that unrealized impairments \"could result in a significant reduction to our net asset value for a given period.\"These disclosures, the complaint challenges, were framed as hypothetical possibilities using words like \"could\" and \"may\" rather than acknowledging problems already underway within the portfolio.What the Lawsuit Contends Was MissingThe securities action asserts that while FS KKR Capital published boilerplate risk factors, the Company simultaneously concealed specific, known deterioration:Non-accrual investments at amortized cost rose from 3.5% in Q1 2025 to 5.3% by Q2 2025 and 5.5% by Q4 2025, surpassing the 3.8% long-term BDC industry averageTotal fair value of investments fell $474 million in Q2 2025 and another $406 million in Q4 2025The Company's dividend was characterized as stable and supported by spillover income, even as the underlying portfolio generating that income was deterioratingQuarterly certifications by senior executives affirmed that disclosure controls were \"effective\" during the same periods when material credit problems went ...